A detailed history of Payden & Rygel transactions in Mckesson Corp stock. As of the latest transaction made, Payden & Rygel holds 39,600 shares of MCK stock, worth $22.9 Million. This represents 1.51% of its overall portfolio holdings.

Number of Shares
39,600
Previous 49,200 19.51%
Holding current value
$22.9 Million
Previous $28.7 Million 31.86%
% of portfolio
1.51%
Previous 2.32%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

SELL
$479.06 - $630.38 $4.6 Million - $6.05 Million
-9,600 Reduced 19.51%
39,600 $19.6 Million
Q2 2024

Oct 07, 2024

BUY
$518.81 - $607.81 $14.9 Million - $17.5 Million
28,800 Added 141.18%
49,200 $28.7 Million
Q1 2024

Oct 08, 2024

SELL
$473.42 - $539.26 $3.03 Million - $3.45 Million
-6,400 Reduced 13.01%
42,800 $23 Million
Q4 2023

Feb 12, 2024

BUY
$437.42 - $470.64 $8.92 Million - $9.6 Million
20,400 New
20,400 $9.45 Million

Others Institutions Holding MCK

About MCKESSON CORP


  • Ticker MCK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Distribution
  • Shares Outstandng 143,730,000
  • Market Cap $83.2B
  • Description
  • McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, International, Medical-Surgical Solutions, and Prescription Technology Solutions (RxTS). The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar, and over-the-counter phar...
More about MCK
Track This Portfolio

Track Payden & Rygel Portfolio

Follow Payden & Rygel and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Payden & Rygel, based on Form 13F filings with the SEC.

News

Stay updated on Payden & Rygel with notifications on news.